SCHEMBL6213432

SCHEMBL6213432

NC(=O)C(Cl)c1cccc(-c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.46
RXRB P28702 1/20 0.46
RXRG P48443 1/20 0.46
MAOA P21397 1/20 0.44
DHODH Q02127 1/20 0.44
KMO O15229 1/20 0.43
IKBKB O14920 1/20 0.42
PRSS1 P07477 1/20 0.42
PRSS2 P07478 1/20 0.42
PRSS3 P35030 1/20 0.42
MGLL Q99685 1/20 0.41
CTSA P10619 2/20 0.40
CTSL P07711 1/20 0.40
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
SIRT1 Q96EB6 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
EPHX1 P07099 1/20 0.40
CASR P41180 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3767845 0.83 PTGS2 (0.50) DHODHIKBKB
SCHEMBL1091960 0.82 EPHX1 (0.48) EPHX1
SCHEMBL6098736 0.80 RXRA (0.47) RXRARXRBRXRGMAOADHODH
SCHEMBL30353435 0.79 RXRA (0.54) RXRARXRBRXRGCTSLCTSS
SCHEMBL27480602 0.79 RXRA (0.54) RXRARXRBRXRGCTSLCTSS
SCHEMBL7283486 0.78 PARP1 (0.50) EPHX1
SCHEMBL11838671 0.77 CSNK2A1 (0.45)
SCHEMBL7282644 0.76 PARP1 (0.48) DHODHHDAC8
SCHEMBL7282003 0.76 PARP1 (0.48) CTSAEPHX1
SCHEMBL7278958 0.76 EPHX1 (0.50) EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509213-A2 ACETAMIDES AND BENZAMIDES THAT ARE USEFUL IN TREATING SEXUAL DYSFUNCTION Abbott Laboratories (US) 2005-03-02 EP disclosed
WO-2003099266-A2 ACETAMIDES AND BENZAMIDES THAT ARE USEFUL IN TREATING SEXUAL DYSFUNCTION ABBOTT LABORATORIES (US) 2003-12-04 WO disclosed